Shareholders Equity: The sum of preferred and common equity items.
Prime Medicine, Inc. (PRME) had Shareholders Equity of $120.87M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$4.63M |
|
$-201.14M |
|
-- |
|
$4.63M |
|
$212.98M |
|
$-208.35M |
|
$7.21M |
|
$-201.14M |
|
$-203.62M |
|
$-201.14M |
|
$-201.14M |
|
$-201.14M |
|
$-203.62M |
|
$-208.35M |
|
$-202.97M |
|
148.76M |
|
148.76M |
|
$-1.35 |
|
$-1.35 |
|
| Balance Sheet Financials | |
$181.29M |
|
$20.57M |
|
$161.44M |
|
$342.73M |
|
$37.45M |
|
-- |
|
$184.42M |
|
$221.87M |
|
$120.87M |
|
$120.87M |
|
|
Shareholders Equity |
$120.87M |
180.51M |
|
| Cash Flow Statement Financials | |
$-162.56M |
|
$-108.76M |
|
$151.51M |
|
$196.54M |
|
$76.72M |
|
$-119.81M |
|
$29.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4498.06% |
|
-4498.06% |
|
-4381.82% |
|
-4342.44% |
|
-4342.44% |
|
$-167.09M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-166.41% |
|
-166.41% |
|
-58.69% |
|
-166.41% |
|
$0.67 |
|
$-1.12 |
|
$-1.09 |
|